| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

Department of Microbial and Molecular Pathogenesis, Texas A&M University Health Science Center,1 Pathobiology Department, College of Veterinary Medicine, Texas A&M University, College Station, Texas2
Received 6 November 2006/ Returned for modification 14 December 2006/ Accepted 29 March 2007
Coxiella burnetii, the etiological agent of Q fever, has two phase variants. Phase I has a complete lipopolysaccharide (LPS), is highly virulent, and causes Q fever in humans and pathology in experimental animals. Phase II lacks an LPS O side chain, is avirulent, and does not grow well in immunocompetent animals. To understand the pathogenicity of Q fever, we investigated the roles of immune components in animals infected with Nine Mile phase I (NM I) or Nine Mile phase II (NM II) bacteria. Immunodeficient mice, including SCID mice (deficient in T and B cells), SCIDbg mice (deficient in T, B, and NK cells), nude mice (deficient in T cells), muMT mice (deficient in B cells), bg mice (deficient in NK cells), mice deficient in tumor necrosis factor alpha (TNF-
/ mice), and mice deficient in gamma interferon (IFN-
/ mice), were compared for their responses to infection. SCID, SCIDbg, nude, and IFN-
/ mice showed high susceptibility to NM I, and TNF-
/ mice showed modest susceptibility. Disease caused by NM I in SCID, SCIDbg, and nude mice progressed slowly, while disease in IFN-
/ and TNF-
/ mice advanced rapidly. B- and NK-cell deficiencies did not enhance clinical disease development or alter bacterial clearance but did increase the severity of histopathological changes, particularly in the absence of B cells. Mice infected with NM II showed no apparent clinical disease, but T-cell-deficient mice had histopathological changes. These results suggest that T cells are critical for clearance of C. burnetii, either NM I or NM II, that IFN-
and TNF-
are essential for the early control of infection, and that B cells are important for the prevention of tissue damage.
Published ahead of print on 16 April 2007.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|